Tonix Pharmaceuticals, Inc.

304 articles with Tonix Pharmaceuticals, Inc.

• TONIX Pharmaceuticals, Inc. Issues Letter to Shareholders

  8/21/2012

• TONIX Pharmaceuticals, Inc. CEO Dr. Seth Lederman Describes Potential Treatment for Fibromyalgia, Post-Traumatic Stress Disorder and Traumatic Brain Injury

  8/16/2012

• TONIX Pharmaceuticals, Inc. Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment

  8/14/2012

• TONIX Pharmaceuticals, Inc. Announces Completion of Clinical Trial of Sublingual TNX-102

  7/30/2012

• TONIX Pharmaceuticals, Inc. Reports Positive Preclinical Data on Sublingual TNX-102

  7/9/2012

• TONIX Pharmaceuticals, Inc. to Present at Marcum MicroCap Conference

  6/19/2012

• TONIX Pharmaceuticals, Inc. Featured on GLX-TV OpenCEOLive Series

  6/14/2012

• TONIX Pharmaceuticals, Inc. CEO Interviewed on CEOLive.TV

  5/23/2012

• TONIX Pharmaceuticals, Inc. Appoints Dr. Samuel Saks to Its Board of Directors

  5/10/2012

• TONIX Pharmaceuticals, Inc. to Present at Three Investor Conferences in May

  4/30/2012

• TONIX Pharmaceuticals, Inc. Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia

  4/6/2012

• TONIX Pharmaceuticals, Inc. Strengthens Management Team With the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development

  4/4/2012

• TONIX Pharmaceuticals, Inc. Holding Corp. Closes on Net Proceeds of $2.0 Million in Second Tranche of a $6.6 Million Private Placement

  3/6/2012

• TONIX Pharmaceuticals, Inc. to Present at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 14, 2012

  2/7/2012

• TONIX Pharmaceuticals, Inc. Closes $4.3 Million Private Placement

  1/23/2012

• TONIX Pharmaceuticals, Inc. to Present at Biotech Showcase and OneMedForum Conferences in San Francisco on January 9 and 10, 2012

  1/4/2012

• TONIX Pharmaceuticals, Inc. to Present at the New York Society of Security Analysts' 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011

  11/21/2011

• TONIX Pharmaceuticals, Inc. Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 for Fibromyalgia

  11/18/2011

• TONIX Pharmaceuticals, Inc. and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement

  10/14/2011

• TONIX Pharmaceuticals, Inc.' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology

  9/7/2011